RxDoctor Payments Data

Sea Kim, MD

Hospice and Palliative Medicine · Alexandria, VANPI 1720295637

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 31.1% of the total. Among hospice and palliative medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,782in general payments, 2019–2025

Across 57 payments — averaging $31.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$554
  • Merz Pharmaceuticals, LLC$509
  • AstraZeneca$234
  • Dexcom, Inc.$134
  • Merz North America, Inc.$83
  • Ipsen Biopharmaceuticals, Inc$79
  • plus $189 from 4 others

What the payments were for

  • Food & beverage$1,782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,782 in reported general payments places this provider in the 90th percentile of 45 hospice and palliative medicine providers in Virginia.

See all hospice and palliative medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$244,729
Medicare patients
488
Services billed
6,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$33,376
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$1,563
Morphine Sulfate ErMorphine Sulfate37$821
Midodrine Hcl17$643
Valsartan20$513
Atorvastatin Calcium63$501
Gabapentin45$422
Metoprolol Succinate25$422
Baclofen13$336
Rosuvastatin Calcium18$285
Morphine Sulfate16$284
Tamsulosin Hcl28$238
Ezetimibe12$199
Levothyroxine Sodium19$189
Losartan Potassium27$172

Paid to pharmacies, not to this prescriber.

Other hospice and palliative medicine in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →